Substance / Medication

Torsemide

Overview

Active Ingredient
torsemide
RxNorm CUI
38413
Labeler: AvKAREUpdated: 2026-02-11T00:00:00.000ZFull label on DailyMed

Contraindications

When this intervention should not be used

Torsemide is contraindicated in patients with known hypersensitivity to torsemide. Torsemide is contraindicated in patients who are anuric. Torsemide is contraindicated in patients with hepatic coma.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Detailed dosage and administration information is available in the full FDA drug label.

View full prescribing information on DailyMed

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

12 trials linked to this intervention

12
Total Trials
2
Recruiting
2
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Torsemide vs. furosemide in congestive heart failure: a systematic-review and meta-analysis on mortality and rehospitalization.
Gudushauri Nino, Polintan Edgar Theodore, Lemonjava Irakli et al. · Acta Cardiol · 2025
PMID: 39910952Meta-Analysis
Efficacy and safety of torsemide versus furosemide in heart failure patients: A systematic review of randomized controlled trials.
Ahmad Cheema Huzaifa, Azeem Saleha, Ejaz Abdullah et al. · Clin Cardiol · 2024
PMID: 37608566Meta-AnalysisFull text (PMC)
Clinical Outcomes With Furosemide Versus Torsemide in Patients With Heart Failure: An Updated Systematic Review and Meta-Analysis.
Siddiqi Ahmed Kamal, Javaid Hira, Ahmed Mushood et al. · Curr Probl Cardiol · 2023
PMID: 37453532Meta-Analysis
Meta-Analysis Comparing Torsemide Versus Furosemide in Patients With Heart Failure.
Abraham Bishoy, Megaly Michael, Sous Mina et al. · Am J Cardiol · 2020
PMID: 31699358Meta-Analysis
Torsemide versus furosemide and intermediate-term outcomes in patients with heart failure: an updated meta-analysis.
Miles Jeremy A, Hanumanthu Balaram K, Patel Kavisha et al. · J Cardiovasc Med (Hagerstown) · 2019
PMID: 30950982Meta-Analysis
Should torsemide be the loop diuretic of choice in systolic heart failure?
DiNicolantonio James J · Future Cardiol · 2012
PMID: 23013124Meta-Analysis
Randomized controlled trial on efficacy and safety of torsemide versus furosemide in patients with nephrotic syndrome.
Bindal Tanvi, Sinha Aditi, Yadav Menka et al. · Pediatr Nephrol · 2026
PMID: 41083751RCT

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Adverse reaction and safety data for this drug is sourced from the FDA-approved label.

View adverse reactions & drug interactions on DailyMed

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Torasemide (substance)
SNOMED CT
108476002
UMLS CUI
C0076840
RxNorm CUI
38413
Labeler
AvKARE

Clinical Data

This intervention maps to 16 entities in the Ltrl knowledge graph.

9
Conditions
4
Biomarkers
2
Specialists
0
Symptoms
12
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.